KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Inventory: 2018-2025

Historic Inventory for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $28.3 million.

  • Twist Bioscience's Inventory rose 17.57% to $28.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 17.57%. This contributed to the annual value of $28.3 million for FY2025, which is 17.57% up from last year.
  • Twist Bioscience's Inventory amounted to $28.3 million in FY2025, which was up 17.57% from $24.1 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Inventory registered a high of $39.3 million during FY2022, and its lowest value of $24.1 million during FY2024.
  • Moreover, its 3-year median value for Inventory was $28.3 million (2025), whereas its average is $28.1 million.
  • Per our database at Business Quant, Twist Bioscience's Inventory spiked by 158.77% in 2021 and then fell by 24.90% in 2024.
  • Twist Bioscience's Inventory (Yearly) stood at $31.8 million in 2021, then increased by 23.61% to $39.3 million in 2022, then decreased by 18.43% to $32.1 million in 2023, then declined by 24.90% to $24.1 million in 2024, then rose by 17.57% to $28.3 million in 2025.